Ascorbate-induced cancellation of nitroxide contrast media enhancement of MR images.
Ascorbate (Vitamin C), a naturally occurring reducing substance, was tested as an in vivo chemical agent to cancel magnetic resonance imaging (MRI) tissue contrast enhancement induced by a nitroxide spin label contrast agent. Paramagnetic nitroxide compounds can be reduced in vitro by ascorbate to nonparamagnetic hydroxylamine derivatives. A nitroxide agent, TES, was injected intravenously, 2 mmol/kg, in 11 anesthetized rats. Renal cortical and hepatic intensities were monitored by serial T1-weighted images (TR/TE 310/15) acquired precontrast and postcontrast. Fourteen minutes after TES administration, ascorbate (1 mmol/kg) was injected in 6 rats, and saline in 5 control rats. At twenty-nine minutes postcontrast, a second TES-injection was given to all rats. The initial TES-injection resulted in a marked enhancement of kidney cortex and liver. Ascorbate administration immediately cancelled this enhancement. Contrast enhancement could be successfully reinduced by a repeat administration of TES. Results indicate that in vivo administration of reducing agents can be used to immediately cancel enhancement induced by nitroxide contrast media, thus nonenhanced images could be obtained after enhanced images without lengthy delays for contrast media elimination.
Wikstrom
M G
MG
Department of Radiology, University of California, San Francisco 94143-0628.
White
D L
DL
Moseley
M E
ME
Dupon
J W
JW
Brasch
R C
RC
D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism*; D003287:Contrast Media / Q000378:metabolism*; D003497:Cyclic N-Oxides / Q000378:metabolism*; D007672:Kidney Cortex / Q000033:anatomy & histology / Q000378:metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains
D003287:Contrast Media; D003497:Cyclic N-Oxides; C038035:N-succinyl-4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl; D001205:Ascorbic Acid